KINARUS THERAPEUTICS (SIX:KNRS)
Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.
KINARUS THERAPEUTICS (SIX:KNRS)
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical
Founded:
2017-09-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.kinarus.com
Total Employee:
11+
Status:
Active
Contact:
+41 79 865 8969
Email Addresses:
[email protected]
Total Funding:
35.05 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Advisors List
Hari Kumar Chairman Of The Board @ Kinarus Therapeutics (SIX:KNRS) Board_member 2021-03-01
Eugene Tierney Member of the Board of Directors @ Kinarus Therapeutics (SIX:KNRS) Board_member 2017-09-01
Alexander Bausch Member of the Board of Directors @ Kinarus Therapeutics (SIX:KNRS) Board_member 2017-09-01
Viktor Boerlin Chief Development Advisor @ Kinarus Therapeutics (SIX:KNRS) Advisor 2017-09-01
Current Employees Featured
Thierry Fumeaux
Thierry Fumeaux Chief Medical Officer @ Kinarus Therapeutics (SIX:KNRS) Chief Medical Officer 2020-09-01
Alexander Bausch
Alexander Bausch CEO and Founder @ Kinarus Therapeutics (SIX:KNRS) CEO and Founder 2017-09-01
Urs Breitenstein
Urs Breitenstein Chief Financial Officer @ Kinarus Therapeutics (SIX:KNRS) Chief Financial Officer 2017-09-01
Claudia Berger
Claudia Berger Chief Clinical Development Officer @ Kinarus Therapeutics (SIX:KNRS) Chief Clinical Development Officer 2017-09-01
Matthew Wright
Matthew Wright Chief Operating Officer and Head of Research @ Kinarus Therapeutics (SIX:KNRS) Chief Operating Officer and Head of Research 2017-09-01
Corinne Peter
Corinne Peter Head of Project Management @ Kinarus Therapeutics (SIX:KNRS) Head of Project Management 2017-09-01
Founder
Alexander Bausch
Stock Details
Company's stock symbol is SIX:KNRS
Investors List
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Debt - Kinarus Therapeutics (SIX:KNRS)
Official Site Inspections
http://www.kinarus.com
- Host name: web4.tup.ch
- IP address: 185.68.66.166
- Location: Bettingen Switzerland
- Latitude: 47.5704
- Longitude: 7.6643
- Timezone: Europe/Zurich
- Postal: 4126
Loading ...